Dermal Fillers Market to Reach Valuation of USD 7.9 Billion by 2028 – Increasing Research and Development (R&D) Initiatives Drives the Market

In terms of revenue, the Global Dermal Fillers Market is expected to reach USD 7.9 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 9.10% from 2022 to 2028.

The increasing awareness about aesthetic beauty, increasing aesthetic beauty requirement because of its benefits, growing introduction of advanced products, and the increasing need for minimally invasive cosmetic procedures are expected to accelerate the growth of the Dermal Fillers Market over the projected time period.

Key Highlights from Report:

· The Hyaluronic Acid segment is accounted to have the largest growth in the Dermal Fillers Market in 2021. These filters are used to improve the skin's contour and minimize depressions in the skin due to injury, scars, or lines. This helps to increase the segmental growth of the Dermal Fillers Market.

· The Face Liftsegment is accounted to hold the potential growth of the Dermal Fillers Market in 2021. Rising consumer awareness of the advantages of dermal fillers and rising healthcare spending on non-surgical aesthetic procedures are some major factors contributing to the segmental growth of the Dermal Fillers Market.

· North America is anticipated to mention the largest growth of the Dermal Fillers Market during the forecast period. The incredibly conscious and financially steady population is accelerating the growth of the Dermal Fillers Market in this region.

Market Dynamics:

Increasing adoption of minimally invasive procedures is expected to propel the growth of the Dermal Fillers Market during the projected time frame. These procedures support numerous benefits such as quicker recovery times, less pain and scarring, and fewer incisions. In addition to this, many market-leading players are started introducing advanced products or collaborating with other market players in order to maintain their strategic growth. For instance, CollPlant, a regenerative and aesthetic medicine company, has granted Allergan Aesthetics to use of its plant-derived recombinant human collagen (rhCollagen) with Allergan Aesthetics' proprietary technologies for the manufacture and commercialization of dermal & soft tissue fillers.

North America is anticipated to mention the largest growth of the Dermal Fillers Market during the forecast period. The high disposable income of people and the growing usage of fillers are the main reason to fuel the growth of the Dermal Fillers Market in this region. In addition, the stringent rules & regulations related to new products will likely propel regional growth of the Dermal Fillers Market. Furthermore, the rising adoption of facial procedures with injectables, the mounting population that spends on aesthetic procedures, and the increase in product availability are also accelerating the growth of the Dermal Fillers Market in this region.

The Global Dermal Fillers Market is Segmented as follows:

• Product
  • Biodegradable
  • Non-Biodegradable
• Material Type
  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Poly-L-Lactic Acid
  • Polymethyl-Methacrylate Microspheres
  • Other Material Types
• Application
  • Facial Line Correction
  • Face Lift
  • Lip Enhancement
  • Other Applications
• End-Use
  • Dermatology Clinics
  • Hospitals
  • Other End Uses
• Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

A list of the Key Players of the Global Dermal Fillers Market is:

AbbVie Inc. (Allergan), Merz Pharma GmbH & Co. KGaA., Galderma S.A, Croma Pharma GmbH., Cytophil Inc., Huons Global Co. Ltd. (Humedix), Prollenium Medical Technologies, Shanghai Bioha Technology Co. Ltd, Sinclair Pharma, Teoxane Laboratories, Zhejiang Jingjia Medical Technology Co. Ltd.

The Global Dermal Fillers Market Scope can be Tabulated as below: